flt3-mutated aml data at ash 2021
Published 2 years ago • 281 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
6:47
the 2021 treatment algorithm for flt3-mutated aml
-
5:02
updates on flt3-mutated aml at ash 2020
-
1:32
novel treatment combinations for flt3-mutated aml
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
6:43
flt3 mutations’ impact on prognosis and treatment in aml
-
7:46
updates in aml treatment and research from asco 2023
-
0:58
flt3 mutation clearance rate in patients with newly diagnosed aml
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
1:49
the prognostic value of flt3-itd residual disease in aml
-
1:33
clinical trials investigating treatment approaches for flt3-mutated and idh-mutated aml patients
-
1:52
the management of r/r flt3-mutated aml
-
8:36
flt3 mutational status can change between diagnosis and relapse in patients with aml
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib
-
1:21
gemtuzumab-based induction chemotherapy with midostaurin in flt3-mutated aml
-
3:14
flt3 mutations for targeted therapy in aml
-
2:15
treatment strategies for patients with aml who possess a flt3 mutation
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
1:44
new targets to treat acute myeloid leukemia (aml) with flt3 mutations
-
0:59
midostaurin: a step forward in the treatment of flt3-mutated aml